AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
Participating in the conference call will be:
Steven H. Collis, Chairman, President & Chief Executive Officer
James F. Cleary, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at investor.amerisourcebergen.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
To access the call via telephone from within
Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on investor.amerisourcebergen.com approximately one hour after the completion of the call and will remain available for one year. The telephone replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephone replay from within
Please check the website investor.amerisourcebergen.com for updates regarding the timing of the live webcasts and for replay information.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20230629779493/en/
Bennett S. Murphy
Senior Vice President, Head of Investor Relations & Treasury
610-727-3693
bmurphy@amerisourcebergen.com
Source: AmerisourceBergen Corporation